Australia's Proteomics climbs on patent for stress diagnostic test
** Shares of Proteomics International Laboratories PIQ.AX climb 5.2% to A$0.51, set for their strongest trading session since March 21, if gains hold ** The biotech firm says patent for its OxiDx oxidative stress diagnostic test has been granted in Australia ** Says co secures new intellectual property protection via the patent grant ** Stock down 36.3% YTD, including current session's moves (Reporting by Nikita Maria Jino in Bengaluru) ((Nikita.Jino@thomsonreuters.com;))
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Launches Share Purchase Plan To Raise Up To A$5 MLN
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius